Viome raised $25 million in a Series D internal round to launch a diagnostics division focused on early-detection tests for chronic diseases and aging.
PRIVATESep 10, 2024
Amount Raised
$25 Million
Round Type
Series D
BellevueOtherBiotechnologyHealth CareScience And EngineeringGenetics
Description
Viome, a longevity and preventative health-focused startup, has secured $25 million to establish a new diagnostics division. The funding will facilitate the development of early-detection tests aimed at chronic diseases, cancer, and aging.
Quick answer
Viome raised $25 Million in a Series D round, dated September 10, 2024. Viome is based in Bellevue, Washington, United States.
How much did Viome raise?
Viome raised $25 Million in a Series D round on September 10, 2024.
What does Viome do?
Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions.
Where is Viome based and how big is it?
Viome is based in Bellevue, Washington, United States. Fundz records about 201 employees.
Who are the decision-makers at Viome?
Fundz holds 2 contacts at Viome, including the Go-to-Market Strategist. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Viome, and when
A new round usually means Viome is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Viome raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Viome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viome. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Viome
Location
Bellevue, Washington, United States
About
Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health.
Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan.
With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging - at its optimum. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.